Transradial PCI in women: Problem solved or clinical equipoise?

Journal of Invasive Cardiology

Volumn 23, Issue 3, 2011, Pages 98-99

  Rao, Sunil V ^a   Krucoff, Mitchell W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ARTERY SPASM; BLEEDING; HUMAN; KIDNEY FAILURE; MORBIDITY; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; RADIAL ARTERY; RISK REDUCTION; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION; TREATMENT FAILURE; VASCULAR ACCESS; VASCULAR DISEASE;

EID: 80155188640     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (17)

1. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: Implications for contemporary practice. J Am Coll Cardiol 2009;53:2019-2027.
2. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-STsegment- elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009;119:1873-1882.
3. Mehta SK, Frutkin AD, Lindsey JB, et al. Bleeding in patients undergoing percutaneous coronary intervention: The development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circulation: Cardiovascular Interventions 2009;2:222-229.
4. Oldgren J, Wernroth L, Stenestrand U. Fibrinolytic therapy and bleeding complications: Risk predictors from RIKS-HIA. Heart 2010;96:1451-1457.
5. Alexander KP, Chen AY, Roe MT, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005;294:3108-3116. (Pubitemid 43016802)
6. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863. (Pubitemid 37430344)
7. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140.
8. Saito S, Ikei H, Hosokawa G, Tanaka S. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Catheter Cardiovasc Interv 1999;46:173-178. (Pubitemid 29066623)
9. Maddury J, Kaushik M, Madhavapeddi A, et al. Feasibility and safety of elective transradial coronary intervention in Asian females. J Invasive Cardiol 2011;23:95-98.
10. Alexander KP, Chen AY, Newby LK, et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 2006;114:1380-1387. (Pubitemid 44462663)
11. Rao SV, Cohen MG, Kandzari DE, et al. The transradial approach to percutaneous coronary intervention: Historical perspective, current concepts, and future directions. J Am Coll Cardiol 2010;55:2187-2195.
12. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the national cardiovascular data registry. J Am Coll Cardiol Intv 2008;1:379-386.
13. Rathore S, Stables RH, Pauriah M, et al. Impact of length and hydrophilic coating of the introducer sheath on radial artery spasm during transradial coronary intervention: A randomized study. J Am Coll Cardiol Intv 2010;3:475-483.
14. Dehghani P, Mohammad A, Bajaj R, et al. Mechanism and predictors of failed transradial approach for percutaneous coronary interventions. J Am Coll Cardiol Intv 2009;2:1057-1064.
15. Bertrand OF, Rao SV, Pancholy S, et al. Transradial approach for coronary angiography and interventions: Results of the first international transradial practice survey. J Am Coll Cardiol Intv 2010;3:1022-1031.
16. Sciahbasi A, Romagnoli E, Burzotta F, et al. Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. Am Heart J 2011;161:172-179.
17. Bertrand OF, Larose E, Rodes-Cabau J, et al. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. Am Heart J 2009;157:164-169.